A randomized parallel-group controlled study for personalized postoperative pain management based on prediction of fentanyl requirements by genetic polymorphisms in patients undergoing orthognathic surgery
Not Applicable
Recruiting
- Conditions
- Pain
- Registration Number
- JPRN-UMIN000006805
- Lead Sponsor
- Tokyo Metropolitan Institute of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Patients less than 15 years and more than 60 years or those with severe complications
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Predictability of Intravenous-Patient-controlled analgesia (IV-PCA) requirements for postoperative 24 h, patient's satisfaction, and/or composite endpoint including side effects
- Secondary Outcome Measures
Name Time Method Intravenous-Patient-controlled analgesia (IV-PCA) requirements for postoperative 24 h, visual analog scale, side effects (heart rate, blood pressure, SpO2, breathing, sedation score)